Our current study firstly demonstrates that Notch3 transcriptionally upregulates PTEN and its downstream pathway by binding to the CSL elements in the PTEN promoter, and leads to the inhibition of breast cancer cell proliferation and migration/invasion. Here, NOTCH3 is linked to breast carcinoma.